Results 221 to 230 of about 19,667,204 (333)
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi+21 more
wiley +1 more source
Distinct troponin C isoform requirements in cardiac and skeletal muscle
Vanessa M Sogah+5 more
semanticscholar +1 more source
Neuronal Nitric-oxide Synthase Interaction with Calmodulin-Troponin C Chimeras [PDF]
Ratan Gachhui+7 more
openalex +1 more source
Solution structure of the TR1C fragment of skeletal muscle troponin-C.
Wendy A. Findlay+2 more
openalex +1 more source
Solution secondary structure of calcium‐saturated troponin C monomer determined by multidimensional heteronuclear NMR spectroscopy [PDF]
Carolyn M. Slupsky+3 more
openalex +1 more source
The METAB‐HTX trial is a prospective cohort study, evaluating cardiac and systemic metabolism among heart transplant recipients. Myocardial function, energetic and metabolism, allograft vasculopathy, allograft rejection, glucometabolism, lipometabolism, liver‐ and kidney function, leucocyte signatures and thromboinflammation will be evaluated ...
Amin Polzin+21 more
wiley +1 more source
HIF1α-dependent mitophagy facilitates cardiomyoblast differentiation [PDF]
Allen, George F. G.+4 more
core +2 more sources
An NMR and spin label study of the effects of binding calcium and troponin I inhibitory peptide to cardiac troponin C [PDF]
Jack W. Howarth+4 more
openalex +1 more source
Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan+10 more
wiley +1 more source